Aaron David Miller, Karim Sadjadpour, Robin Wright
{
"authors": [
"Karim Sadjadpour"
],
"type": "legacyinthemedia",
"centerAffiliationAll": "dc",
"centers": [
"Carnegie Endowment for International Peace"
],
"collections": [],
"englishNewsletterAll": "menaTransitions",
"nonEnglishNewsletterAll": "",
"primaryCenter": "Carnegie Endowment for International Peace",
"programAffiliation": "MEP",
"programs": [
"Middle East"
],
"projects": [],
"regions": [
"Middle East",
"Iran"
],
"topics": [
"Political Reform",
"Nuclear Policy"
]
}Source: Getty
Iran is ‘Years Away’ from a Nuclear Weapon
Concern over Iran’s nuclear program often ignores the fact that Iran is still a significant amount of time from actually acquiring a nuclear weapon. This leaves policymakers with ample time to engage in diplomacy and develop coercive sanctions.
Source: MSNBC's Morning Joe
Speaking on MSNBC's Morning Joe, Carnegie's Karim Sadjadpour stated that, as tensions between the Obama administration and Israel over Iran’s nuclear program continue, much discussion has focused on whether or not Iran can be counted on as a rational actor in international politics. Sadjadpour explained that “Iran is a rational actor in the sense that staying in power is paramount. The regime is homicidal but it is not suicidal.” However, it will ultimately prove extremely difficult to reach a modus vivendi with a regime that relies on anti-Americanism as an inextricable component of its ideology, Sadjadpour added.
One of the chief points of contention between the Obama administration and the Israelis centers on how far away Iran is from developing the capacity to weaponize its nuclear program. Sadjadpour said that the Iranians are at a minimum of two years before they will be able to have the bomb. “The reality is we often talk ourselves into hyperventilation on this issue, but there is still a significant amount of time to engage in diplomacy,” he concluded.
About the Author
Senior Fellow, Middle East Program
Karim Sadjadpour is a senior fellow at the Carnegie Endowment for International Peace, where he focuses on Iran and U.S. foreign policy toward the Middle East.
- What’s Keeping the Iranian Regime in Power—for NowQ&A
- How Washington and Tehran Are Assessing Their Next StepsQ&A
Aaron David Miller, David Petraeus, Karim Sadjadpour
Recent Work
Carnegie India does not take institutional positions on public policy issues; the views represented herein are those of the author(s) and do not necessarily reflect the views of Carnegie, its staff, or its trustees.
More Work from Carnegie India
- Risk and Retaliation: Israel, Iran, and the Evolving Situation in West AsiaArticle
An Israeli response to Iran’s October 1 attack is imminent. The key question is of its intensity and potential fallout, both within Iran, in terms of nuclear security policy changes, and across the broader region. The coming days are likely to reshape West Asia irreversibly.
Gaddam Dharmendra
- How WHO’s “One Health” Program Can Help India Tackle MonkeypoxCommentary
With monkeypox being declared a global health emergency, the WHO approach is an innovative and effective way to curb outbreaks of zoonotic diseases.
Shruti Sharma
- Lessons from the Coronavirus Pandemic: Leveraging Biotechnology to Tackle Infectious Diseases in IndiaPaper
In India, biotechnology has played an important role in helping stakeholders in academia, industry, and government develop new pandemic-related technology, from test kits to respiratory devices. But these biotechnology advancements can go further to strengthen India’s public health capacity.
Shruti Sharma
- Combating Vaccine Hesitancy in IndiaCommentary
Unless the government can up its communications game, anti-vax movements could prolong India’s pandemic effects.
Shruti Sharma
- How Should Countries Study Viruses Safely?Commentary
The uncertain origin of the coronavirus has focused attention on gain-of-function research—studying viruses to learn how they spread. How can countries work together to ensure stringent safety standards?
Shruti Sharma